skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

What Skipta Does

Skipta_logo

The Skipta Network offers membership free of charge to verified and credentialed healthcare professionals enabling communication, collaboration and information exchange within a private and secure platform organized by physician specialty, healthcare profession or disease state.  Skipta supports the medical advancement of its members by offering a range of collaborative peer based services that aid quality of care and contribute to improved patient outcomes. Each community is vertically aligned, ensuring members are interacting with liked-minded colleagues, sharing similar clinical experiences, collaborating on shared challenges, successes and the latest clinical news and information relevant to their profession.  

CORE PRODUCTS


The Skipta Network provides multi-touch opportunities for the life-science industry to engage, interact with, and learn from verified healthcare professionals through a trusted and specialized digital community.  

The Engagement Suite of products provides a variety of opportunities, including dedicated emails of client-supplied content, banner advertisements within the community, and weekly community eNewsletters as well as, interactive tactics that encourage interaction among a targeted and verified audience.

The Market Research Suite of products enables the digital collection of insights and analysis occurring between verified healthcare professionals within their community.  Opportunities include virtual market research, qualitative and quantitative surveys, as well as tailored research projects designed to meet specific research objectives.

無料の最新記事&レポート

  • Trialtrove: 医療用医薬品の臨床試験情報データベース, Medtrack: 製薬企業などヘルスケア企業情報のデ...

    オンラインセミナー:バイオ医薬品産業におけるオーストラリアの強み

    23 Oct 2019

    オーストラリアは今や世界のバイオ医薬品産業において重要な位置を占めるようになりました。国の政策の後押しや質の高い治験環境、産学連携など様々な要因が他国と比較してオーストラリアに優位性を与えています。世界的なバイオ医薬品産業の動向の中に位置づけて、同国市場の強みについて弊社アナリストが解説します。

    Topic biopharmaceutical clinical-trials

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    2018年に開始された臨床試験を総括・無料ホワイトペーパー

    18 Oct 2019

    2018年に開始された第I相臨床試験~第III相臨床試験を総括する無料ホワイトペーパー「2018 Clinical Trials Roundup: Surveying the Landscape of 2018 Trial Starts(全22頁)」をダウンロードできます。2018年に開始された臨床試験とその競合状況を鳥の目で分析して、バイオ医薬品産業全体のトレンドを明らかにしています。また、個々の企業の戦略や優先課題も考察しています。

    Topic drug-development-landscape biopharmaceutical business-strategies

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Trialtrove 2018 Clinical Trials Roundup Surveying the Landscape of 2018 Trial Starts infographic

    11 Oct 2019

    Trialtrove 2018 Clinical Trials Roundup Surveying the Landscape of 2018 Trial Starts infographic

    A clear view of the past is often the surest way to plan for the future. The annual analysis of Phase I-III clinical trials from Citeline’s Trialtrove reveals the priorities and strategies of the biopharma industry. This infographic lets you clearly see the players, trials, and trends.  

    Topic drug-development-landscape biopharmaceutical business-strategies

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Trialtrove 2018 Completed Clinical Trials Snapshot

    12 Aug 2019

    Get a visual snapshot of how the industry pipelines are faring with our 2018 Completed Trials snapshot. This graphic analysis paints a clear picture of the state of clinical trial completions, while pointing to some important changes that are emerging.  

    Topic clinical-trials drug-development-landscape

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    2018年に終了した臨床試験~製薬企業による臨床開発動向

    12 Aug 2019

    無料ホワイトペーパー『2018年に終了した臨床試験~製薬企業による臨床開発動向/原題:2018 Completed Trials: State of Industry-Sponsored Clinical Development』が発行されました。インフォーマ・ファーマインテリジェンスでは過去4年に渡って同様のホワイトペーパーを発行してきました。今年も2018年に完了したフェーズI~III/IVまでの合計4,864の臨床試験と開発中止となった762の試験について、19個の図表を用いて解説しています。

    Topic drug-development-landscape

  • Sitetrove: 治験責任医師と治験施設情報のデータベース, Trialtrove: 医療用医薬品の臨床試験情報デー...

    Citeline: Global Clinical Trial Intelligence Solutions

    02 Jul 2019

    Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.

    Topic Clinical trials Clinical trial optimization

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    がん臨床試験に対する投資額の効果を探る

    25 Jun 2019

    がん臨床試験に対する投資額の効果を探る無料ホワイトペーパー「A Decade in Review: Oncology Trial Benchmarks and Sponsor Analysis」が発行されました。競争が激しくなる中、医薬品業界全体で様々なレベルの投資が行われており、新薬を市場に投入するための平均コストは上昇し続けています。このような投資額の増加は臨床試験の実施状況にどのような影響を与えているのでしょうか。

    Topic clinical-trials cancer

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    2017 Clinical Trials Roundup The Evolution Continues

    By Doro Shin 15 Jun 2019

    For a detailed look at the statistics and trends surrounding clinical trials initiated in 2017, we invite you to download 2017 Clinical Trials Roundup: The Evolution Continues. Using a wealth of trial data from Trialtrove, this information-packed white paper provides a detailed analysis of Phase I–III clinical trials that were initiated last year.

    Topic clinical-trials

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    From STEP to PrEP

    By Jonathan Slater 07 Mar 2019

    In June 2016, all United Nations Member States pledged to end the AIDS epidemic as a public health threat by 2030 and signed up to time-bound targets.

    Topic drug-development-landscape diseases

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    2017 Completed Trials

    19 Oct 2018

    As Informa Pharma Intelligence has done for the past three years, this analysis examines the landscape of industry-sponsored clinical trials completed during 2017, of which there were a total of 3,534 Phase I through Phase III/IV. The nearly 700 trials terminated in 2017 were not included in this analysis.

    Topic clinical-trials

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Rheumatoid Arthritis - Old and New Approaches Shifting the Treatment Paradigm

    By Laura Runkel 19 Oct 2018

    Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Sepsis and the Receding Grail

    05 Jan 2018

    Sepsis is a life-threatening illness culminating in multi-organ dysfunction paired with a systemic inflammatory response. The disease burden is considerable: it is the single most expensive condition treated in hospitals, with annual costs in the US projected at nearly $24bn.

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Is China the Dark Horse in Clinical Development?

    30 Nov 2017

    Over the last decade, it is undeniable that China has emerged as a rising star in pharmaceutical R&D

    Topic clinical-trials

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    2016 Clinical Trials Round up Webinar Recording

    25 Sep 2017

    Watch the latest webinar on Clinical Trials

    Topic clinical-trials

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Breast cancer PGX biomarker trials leading the way

    09 Aug 2017

    Breast cancer PGX biomarker trials leading the way

    Breast cancer trials are making the most use of personalized medicine developments in trials, according to data gathered by Trialtrove.

    Topic clinical-trials-blog clinical-trials